Teleflex to Present at the 2nd Annual Congress of the European Society for Vascular Medicine (ESVM)
May 02 2016 - 6:30AM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies for critical care, urology and surgery, will
showcase its Arrow® Interventional Access Portfolio at the 2nd
Annual Congress of the European Society for Vascular Medicine
(ESVM) to be held in Rome, Italy on May 8 – 10, 2016.
During the event, Teleflex will highlight the Arrow® GPSCath®
Balloon Dilatation Catheter featuring innovative VisioValve®
Technology over a 0.014 guidewire - for infrapopliteal
interventions.
The Arrow® GPSCath® Catheter is a specialty two-in-one device
that is indicated for percutaneous transluminal angioplasty (PTA)
in the peripheral vasculature, including iliac, femoral, popliteal,
infrapopliteal and renal arteries allowing the physician to conduct
angioplasty and inject fluid (targeted angiogram specifically at
lesion site) while maintaining catheter and guidewire position.
Below-the-knee interventions can be complex undertakings, requiring
multiple devices, numerous procedural steps and significant
procedural time. The Arrow® GPSCath® Catheter offers a solution by
combining angioplasty and angiography into one device.
Prof. Marianne Brodmann, University Hospital Graz, Austria, will
present the Arrow® GPSCath® Balloon Dilatation Catheter with a
recorded live-case "Popliteal and BTK trifurcation occlusion in
dialyzed diabetic Rutherford 5" on Monday May 9, at 10:09 a.m.,
during the Symposium: Endovascular Techniques and Arterial
Revascularisation held from 09:00-10:30 a.m. in the Dali
Auditorium.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® – trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, GPSCath, Hudson
RCI, LMA, Pilling, Rüsch, VisioValve and Weck are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates,
in the U.S. and/or other countries. © 2016 Teleflex Incorporated.
All rights reserved.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160502005129/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836orMartina Teichmann-ZindlerDirector
Marketing Communications International+49
(0)7151-406-538martina.teichmann@teleflex.com
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024